Literature DB >> 2420005

Tyr527 is phosphorylated in pp60c-src: implications for regulation.

J A Cooper, K L Gould, C A Cartwright, T Hunter.   

Abstract

The Rous sarcoma virus oncogene product, pp60v-src, transforms cultured fibroblasts but its corresponding proto-oncogene product, pp60c-src, does not. Both proteins are known to be protein-tyrosine kinases. Published results suggest that the kinase activity of pp60c-src is inhibited relative to that of pp60v-src, due perhaps to phosphorylation of a tyrosine in pp60c-src that is not phosphorylated in pp60v-src. In this study, it was observed that the tyrosine phosphorylated in pp60c-src is Tyr527, six residues from the COOH-terminus of the protein. The region of pp60c-src from residue 515 to the COOH-terminus, including Tyr527, has been replaced with a different sequence in pp60v-src. Thus, the increase in transforming ability and kinase activity that occurred in the genesis of pp60v-src may have resulted from the loss of a tyrosine involved in negative regulation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420005     DOI: 10.1126/science.2420005

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  189 in total

1.  The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation.

Authors:  T Shishido; T Akagi; T Ouchi; M M Georgescu; W Y Langdon; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Role of p34cdc2-mediated phosphorylations in two-step activation of pp60c-src during mitosis.

Authors:  S Shenoy; I Chackalaparampil; S Bagrodia; P H Lin; D Shalloway
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

3.  Control of src kinase activity by activators, inhibitors, and substrate chaperones.

Authors:  M Abdel-Ghany; K el-Gendy; S Zhang; E Racker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  A highly efficient retroviral vector allows detection of the transforming activity of the human c-fps/fes proto-oncogene.

Authors:  R A Feldman; D R Lowy; W C Vass; T J Velu
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

5.  Tyrosine phosphorylation of a c-Src-like protein is increased in membranes of CD4- CD8- T lymphocytes from lpr/lpr mice.

Authors:  T Katagiri; J P Ting; R Dy; C Prokop; P Cohen; H S Earp
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

Review 6.  Src signaling pathways in prostate cancer.

Authors:  Andreas Varkaris; Anastasia D Katsiampoura; John C Araujo; Gary E Gallick; Paul G Corn
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

7.  Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae.

Authors:  S M Murphy; M Bergman; D O Morgan
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

8.  Myristylation is required for Tyr-527 dephosphorylation and activation of pp60c-src in mitosis.

Authors:  S Bagrodia; S J Taylor; D Shalloway
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

9.  Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance.

Authors:  G Payne; S E Shoelson; G D Gish; T Pawson; C T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

10.  Amplification of MPZL1/PZR gene in hepatocellular carcinoma.

Authors:  Yao-Tsung Yeh; Hong-Ying Dai; Ching-Yen Chien
Journal:  Hepatobiliary Surg Nutr       Date:  2014-04       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.